Democratizing hedge fund level analysis tools for everyone
| Name | Darya-Varia Laboratoria Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Blue Sphere Singapore Pte Ltd | 92.12 | 92.12 |
| Public < 5% | 7.88 | 7.88 |
| Source | 2022 | 2021 |
|---|---|---|
| 1349 | DVLA | F2 |
| 1350 | DVLA | F2 |
| 1351 | DVLA | F2 |
| 1352 | DVLA | F2 |
| 1354 | DVLA | F2 |
| 1353 | DVLA | F2 |
| Region | 2022 | 2021 |
|---|---|---|
| 820 | DVLA | F2 |
| 821 | DVLA | F2 |
| 822 | DVLA | F2 |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 0.87 | # 6 / 15 |
| EV_EBITDA | 7.13 | # 3 / 15 |
| PER | 8.43 | # 1 / 15 |
| PBV | 1.19 | # 5 / 15 |
| DER | 0.56 | # 6 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | 10.093 | # 6 / 15 |
| ROA % | 9.180000000000001 | # 7 / 15 |
| ROE % | 13.900000000000002 | # 8 / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2024 | 108.0 | 6.8 |
| 2023 | 121.0 | 7.300000000000001 |
| 2022 | 116.0 | 4.9 |
| 2021 | 112.0 | 4.1 |
| 2020 | 107.0 | 4.4 |
| 2019 | 107.0 | 4.7 |
| 2018 | 37.0 | 1.6 |
| Timeframe | Performance |
|---|---|
| 1W % | 1.8 |
| 1Mo % | 1.5 |
| 3Mo % | 1.8 |
| 1Yr % | 7.3 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 14.94 | 52.43 T | 53.67 T | 34,651 B | 5,348 B | 3,508 B |
| SOHO | 57.58 | 33.76 T | 36.00 T | 10,566 B | 742 B | 587 B |
| SIDO | 14.43 | 15.75 T | 15.31 T | 3,639 B | 1,481 B | 1,091 B |
| TSPC | 8.35 | 12.67 T | 11.15 T | 13,512 B | 2,016 B | 1,515 B |
| PYFA | -9.55 | 4.67 T | 10.70 T | 2,747 B | -142 B | -488 B |
| MDLA | 8.92 | 3.45 T | 6.04 T | 14,788 B | 557 B | 386 B |